BlossomHill Therapeutics Inc.
BLSM | NASDAQ
$26.66
-$0.14 (-0.52%)
Sep 22, 2026, 9:39 AM ET · Market open
TTM Period Ending | Q1 2026 Mar 30, 2026 | Q1 2025 Mar 30, 2025 |
|---|---|---|
Revenue | n/a | n/a |
Cost of Revenue | n/a | n/a |
Gross Profit | n/a | n/a |
Operating Income | -22.11M | -11.45M |
Interest Income | 1.1M | 976K |
Pretax Income | -21.01M | -10.48M |
Net Income | -21.01M | -10.48M |
Selling & General & Admin | 2.21M | 1.88M |
Research & Development | 19.9M | 9.57M |
Other Expenses | n/a | n/a |
Operating Expenses | 22.11M | 11.45M |
Interest Expense | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a |
Cost & Expenses | 22.11M | 11.45M |
Income Tax Expense | n/a | n/a |
Shares Outstanding (Basic) | 29.08M | 29.08M |
Shares Outstanding (Diluted) | 29.08M | 29.08M |
EPS (Basic) | -0.72 | -0.36 |
EPS (Diluted) | -0.72 | -0.36 |
EBITDA | -21.98M | -11.37M |
EBIT | -22.11M | -11.45M |
Depreciation & Amortization | 125K | 85K |
Add to Watchlist
Select watchlists to add or remove BLSM